Skip to main content

Specialty Pharmacy

  • Rx Timer Cap introduces easy-to-remove version

    LOS ANGELES — Rx Timer Cap has introduced a new version of the cap designed for ease of use among elderly patients.

    The company announced Tuesday the introduction of the new EZ-Twist removal system for making the cap easy to open and close for people who don't require childproof caps.

  • CVS expands ExtraCare loyalty card program to reward customers for filling prescriptions

    WOONSOCKET, R.I. — CVS Caremark has launched what it called the "latest evolution" of its ExtraCare loyalty card program.

    The chain announced Monday the launch of the ExtraCare Pharmacy & Health Rewards program, which allows members to earn larger and more frequent rewards when filling prescriptions or making healthy decisions, as well as providing another choice for members and giving them the ability to opt-in to parts of the program most relevant to their needs and preferences.

  • Rexam, Rx Timer Cap partner to promote medication adherence

    PERRYSBURG, Ohio — Prescription vial manufacturer Rexam has a deal with Rx Timer Cap to adapt the cap to its vials, Rexam said.

    Rexam said the partnership would help improve medication adherence. The Rx Timer Cap has a built-in LCD timer that automatically counts the minutes and hours since patients last took their medication.

  • H. D. Smith names new EVP for specialty arm Smith Medical Partners

    SPRINGFIELD, Ill. — H. D. Smith on Monday announced the appointment of Tim Booth to EVP, Smith Medical Partners. Smith Medical Partners is a wholly owned subsidiary of H. D. Smith focused on specialty pharmaceutical distribution and services, and is part of the newly formed H. D. Smith Specialty Solutions group.

  • FDA approves generic cancer drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a generic version of a cancer drug in a move that the agency said would help relieve shortages.

    The FDA announced the approval of Sun Pharma Global's doxorubicin hydrochloride liposome injection, a generic version of Johnson & Johnson's Doxil. The drug is currently on the agency's list of drugs experiencing shortages.

  • Study finds men on long-acting opioids have lower testosterone

    OAKLAND, Calif. — Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

    The study, which the healthcare system called the first to show a significant difference in risk between short-acting and long-acting opioids, appeared in The Clinical Journal of Pain.

  • FDA approves new drug for potentially deadly ammonia conditions

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating some disorders that harm the body's ability to remove ammonia from the blood, the agency said Friday.

  • NCPDP releases updated acetaminophen white paper

    SCOTTSDALE, Ariz. — A standards-development organization for the pharmacy services industry has updated a white paper on protecting consumers and patients from accidental overdoses of the painkiller acetaminophen.

    The NCPDP announced the updated white paper, "NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen Version 1.1."

X
This ad will auto-close in 10 seconds